Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d367eed6378c49d080dbbbe9f31a9f50 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
filingDate |
2019-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ec4728c13835d4a53e826cd4ea9dae5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6166804a4d84244a68ecd2a389b743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d50a5b047996f53b678731e158e1544 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9af873bdddf9d915c5f078af0270f419 |
publicationDate |
2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020128616-A2 |
titleOfInvention |
Methods and compositions for controlling cell migration and proliferation |
abstract |
Compositions and methods of treating epithelial damages with an effective amount of a peptide agent including amino acid sequence LKKTET (SEQ ID NO: 1) or LKKTNT (SEQ ID NO: 2), or variants thereof are provided. The presently disclosed subject matter provides compositions and methods for treating epithelial damages and accelerating the healing of a damaged eye or skin by activating a P2X7 purinergic receptor. |
priorityDate |
2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |